Showing results (3111-3120 of 10,080) with videos related to
Sort By:
Pageof 1,008
Current Pharmaceutical Design|May 29, 2012
Rikkunshito and ghrelin secretionHiroshi Takeda, Shuichi Muto, Koji Nakagawa, et al.Current Pharmaceutical Design|June 2, 2012
A leap into the chemical space of protein-protein interaction inhibitorsB O Villoutreix, C M Labbé, D Lagorce, et al.Current Pharmaceutical Design|May 18, 2012
Immune dysfunction in chronic lymphocytic leukemia: the role for immunotherapyJohn C Riches, Alan G Ramsay, John G GribbenCurrent Pharmaceutical Design|May 18, 2012
The role of B cell receptor stimulation in CLL pathogenesisLaurens P Kil, Saravanan Yuvaraj, Anton W Langerak, et al.Current Pharmaceutical Design|May 18, 2012
Therapy of elderly/comorbid patients with chronic lymphocytic leukemiaLukas SmolejCurrent Pharmaceutical Design|May 18, 2012
The role of bevacizumab in advanced epithelial ovarian cancerJudith R Kroep, Johan W R NortierCurrent Pharmaceutical Design|May 18, 2012
Trabectedin as a new chemotherapy option in the treatment of relapsed platinum sensitive ovarian cancerBradley J Monk, Heather Dalton, Ivor Benjamin, et al.Current Pharmaceutical Design|November 24, 2012
Pharmacological properties of glutamatergic drugs targeting NMDA receptors and their application in major depressionGianluca Serafini, Maurizio Pompili, Marco Innamorati, et al.Current Pharmaceutical Design|November 24, 2012
Chronic hyperuricemia, uric acid deposit and cardiovascular riskDavide Grassi, Livia Ferri, Giovambattista Desideri, et al.Current Pharmaceutical Design|November 27, 2012
Angiotensin II type 1 and type 2 receptor-induced cell signalingHiroshi Akazawa, Masamichi Yano, Chizuru Yabumoto, et al.Pageof 1,008